Melbourne, Victoria, 3004 Australia

Mission Statement

We work collaboratively with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes.

About This Cause

Every year, over 17,000 Australians are diagnosed with invasive melanoma and around 1,400 Australians will lose their life to this deadly cancer that can affect young and old. Melanoma and Skin Cancer Trials is conquering these cancers through clinical trials. Over the past 25 years, more than 7,000 patients have accessed our clinical trials that may have improved their quality of life, prevented them from undergoing debilitating treatments, and for some, given them more time with loved ones. The high-quality evidence published from our clinical trials improves melanoma and skin cancer outcomes. We are the only independent, not-for-profit, multi-site, collaborative clinical trials group focused on melanoma and skin cancer in Australia and New Zealand. Our clinical trials portfolio covers the prevention, early detection and treatment of melanoma and skin cancer, including early to late phase clinical trials. Importantly, we also investigate rare forms of skin cancer such as Merkel cell carcinoma and melanoma of the eye. We value the lived experiences of consumers, and our collaborative approach ensures their unique perspectives are considered in clinical trial prioritisation, development, and implementation. We also believe all Australians and New Zealanders should be able to access clinical trials, which is why we continue to work with our networks to open more trial sites in regional Australia and in New Zealand. Melanoma and Skin Cancer Trials continues to be supported by the Australian Government via Cancer Australia, Monash University, and the generosity of our industry partners and donors. Our academic affiliation with Monash University enhances our research activities.

553 St Kilda Road
Melbourne, Victoria 3004
Phone +61 3 9903 9022
Twitter @MASC_Trials
Unique Identifier 70626908512